My opinion in response to Balleroni question: 1 I
Post# of 36537
(Total Views: 352)
Posted On: 06/15/2021 8:38:34 PM
My opinion in response to Balleroni question:
1 Ipo
2 ipo
3 ipo
Once the smoke and minors of “quiet time” is in our rear view we will hopefully be able to do at least what we were projected to do in 2018 when our pps was ~$2 ps.
This was pre Covid and pre vaccine hype. Personally the IND doesn’t even make my top 10 because for me that foreshadows another year of promises, missed timelines, and disappointments- and lots and lots of unanswered questions- over and over and over. For that reason, If and when the ipo arrives, I will need to take a Gnbt monitoring break for the sake of my emotional well being. I am not chasing the GNBT Covid carrot for 9-12 or whatever months. Joe deserves a lot of credit for what he has done but that credit is beginning to wear thin. We need the ipo yesterday. I personally don’t care about the A/B stock business. Found $. I think it’s good to put some limits otherwise many people would dump- especially considering some of sentiment expressed on this board. I am holding steady for the moment and hoping that in the month of the 11th year anniversary of FDA AE37 patent approval we will hear good news on the ipo.
1 Ipo
2 ipo
3 ipo
Once the smoke and minors of “quiet time” is in our rear view we will hopefully be able to do at least what we were projected to do in 2018 when our pps was ~$2 ps.
This was pre Covid and pre vaccine hype. Personally the IND doesn’t even make my top 10 because for me that foreshadows another year of promises, missed timelines, and disappointments- and lots and lots of unanswered questions- over and over and over. For that reason, If and when the ipo arrives, I will need to take a Gnbt monitoring break for the sake of my emotional well being. I am not chasing the GNBT Covid carrot for 9-12 or whatever months. Joe deserves a lot of credit for what he has done but that credit is beginning to wear thin. We need the ipo yesterday. I personally don’t care about the A/B stock business. Found $. I think it’s good to put some limits otherwise many people would dump- especially considering some of sentiment expressed on this board. I am holding steady for the moment and hoping that in the month of the 11th year anniversary of FDA AE37 patent approval we will hear good news on the ipo.
(3)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼